This site uses cookies to store information on your computer. Learn more x

DSM presenting on next generation antibacterial medical coatings and biomaterials at the BioInterface 2011 Annual Conference

Berkeley CA, US, 17 Oct 2011 17:15 CEST

DSM, a global leader in biomedical materials science, today announced the Company will be participating at the Surfaces in Biomaterials Foundation’s BioInterface 2011 Conference, which will be held October 24-26 in Bloomington, Minnesota. Marc Hendriks, director of global R&D and technology at DSM Biomedical, is acting president of the foundation.

Marc Hendriks will be this year’s symposium chair and on October 25th, he will chair a point-counterpoint debate in which experts will discuss the postulation that surface-immobilized heparin is the most optimal blood compatible biointerface. During an October 26th presentation, Ton Dirks, Senior Scientist Medical Coatings, will present on “Non-Adhesive and Antimicrobial Coatings for Medical Implants” which covers an overview of DSM’s antibacterial and bacteria-repellent coating solutions that are designed to prevent biomaterial-associated infections. Also on October 26th, Aylvin Dias, DSM Principal Scientist, is co-chairing a session about surgical biomaterials where presenters will highlight recent progress in surgical adhesion barriers, hemostats, sealants and adhesives.

“Driven by industry trends like device miniaturization, infection prevention and cost control, the biomaterials industry continues to see significant innovation,” said Marc Hendriks. “This year’s BioInterface conference will provide a tremendous overview of innovative biomaterials science applications, highlighting how biomaterials and device companies are coming together in new ways to develop smarter devices designed to promote shorter recovery time for patients, enable improvement in quality of life and reduce overall costs.”

DSM’s presence at the Conference aligns with the Company’s ongoing drive for open innovation, tapping into the wider academic community and device making industry to help develop breakthrough technologies that benefit clinical outcomes worldwide. The presentations will highlight DSM Biomedical’s expanding materials portfolio and sustainable coating processes as well as provide technical results from testing.

For more information on the conference please visit the BioInterface 2011 website.